Latest S-1 registration statements

ReShape Lifesciences is launching a best-efforts offering of up to 1,779,360 units, each containing a share of common stock or a pre-funded warrant and a warrant, aiming to raise capital for general corporate purposes including merger expenses.

Currenc Group Inc. announces a purchase agreement with Arena Business Solutions for the potential issuance and sale of up to $10 million in ordinary shares.

Mighty Fire Breaker partners with the EPA's Safer Choice program to advance environmentally friendly fire-fighting products and seeks NYSE American listing.

Lifeward Ltd. is filing an amendment to its registration statement for the resale of up to 1.9 million ordinary shares issuable upon the exercise of outstanding warrants.

Kraig Biocraft Laboratories files a pre-effective amendment to its Form S-1 registration statement, primarily related to exhibits and legal opinions, with no new securities being registered.

Curanex Pharmaceuticals is seeking to raise capital through a $10 million IPO to fund the clinical development of its lead botanical drug candidate, Phyto-N, and pursue Nasdaq listing.

Petros Pharmaceuticals, Inc. is launching a securities offering amidst significant financial challenges, including ongoing losses, a going concern qualification, and a potential delisting from The Nasdaq Capital Market.

Franklin Crypto Trust's new ETF seeks to mirror the CF Institutional Digital Asset Index, initially focusing on Bitcoin and Ether.

N2OFF Inc. is registering for the resale of up to 53.1 million shares of common stock by selling stockholders, including shares from a recent private placement and warrants.

Revium Rx, formerly OC Beverages, files an S-1 registration statement for an initial public offering of units and resale of common stock by selling stockholders.

Functional Brands Inc., formerly HT Naturals Inc., files an amendment to its S-1 registration statement for a proposed initial public offering of common stock and warrants.

ReShape Lifesciences is seeking to raise capital through a unit offering to fund operations while it awaits the closing of its merger with Vyome Therapeutics and the sale of its assets to Ninjour Health International.

Cloudastructure, Inc. files an amendment to its Form S-1 registration statement, paving the way for the resale of up to 7,865,915 shares of Class A common stock by selling stockholders.

Aptose Biosciences has filed a registration statement for the potential resale of up to 12,030,218 common shares by Keystone Capital Partners, following a recent purchase agreement.

ProShares Trust II seeks SEC registration for nine ETFs offering leveraged and inverse exposure to various benchmarks, including Euro, Yen, natural gas, gold, silver, and VIX futures.

Kraig Biocraft Laboratories files an amendment to its Form S-1 registration statement related to a proposed offering of Class A Common Stock.

Helio Corporation, an aerospace company specializing in space flight hardware and services, has filed an S-1/A registration statement for a firm commitment public offering of 3,333,334 shares of common stock, with an estimated IPO price between $4.00 and $5.00 per share.

IMAC Holdings intends to raise up to $60 million through an equity line of credit to support its proteomics business, focusing on oncology treatment decisions.

Live Oak Acquisition Corp. V, a blank check company, is set to launch its initial public offering, offering 20,000,000 units at $10.00 each to pursue a business combination.

Rubber Leaf Inc, a Nevada-based automotive rubber and plastic sealing strip manufacturer, aims to raise capital and list on the Nasdaq Capital Market through a firm commitment public offering.

Petros Pharmaceuticals aims to raise up to $20 million through a unit offering to advance its platform for prescription-to-over-the-counter medication switches.

SCWorx Corp. is registering the resale of up to 40 million shares of its common stock by selling stockholders, as detailed in a recent SEC filing.

Cloudastructure, Inc. files Amendment No. 1 to its Form S-1 registration statement, covering the potential resale of up to 7,865,915 shares of Class A common stock by selling stockholders.

Sonder Holdings seeks to register the resale of over 127 million shares of common stock by existing stockholders, amidst concerns about the company's ability to continue as a going concern.

Shuttle Pharmaceuticals plans a firm commitment underwritten offering of common stock and pre-funded warrants to advance its cancer treatment pipeline.

ReShape Lifesciences details the terms of common stock purchase warrants and a merger agreement with Vyome Therapeutics, outlining exercise conditions, price adjustments, and potential alternative considerations.

Celularity Inc. announces a proposed public offering of Class A common stock and pre-funded warrants to raise capital.

Functional Brands Inc. has filed an amendment to its Form S-1 registration statement, primarily to include exhibits related to the specimen common stock certificate and forms for Series A and Series B warrants.

Ludwig Enterprises, Inc., a genomics technology company, has filed an S-1 registration statement for a firm commitment public offering to fund the development and launch of its mRNA genetic testing kits.

SailPoint, Inc. files a Form S-1MEF registration statement to register additional shares of common stock, representing no more than 20% of the initial offering price.